Suppr超能文献

慢性肺移植功能障碍的感染触发因素。

Infectious Triggers of Chronic Lung Allograft Dysfunction.

作者信息

Gregson Aric L

机构信息

Division of Infectious Diseases, Department of Medicine, University of California, Box 957119, Warren Hall 14-154, Los Angeles, CA, 90995-7119, USA.

出版信息

Curr Infect Dis Rep. 2016 Jul;18(7):21. doi: 10.1007/s11908-016-0529-6.

Abstract

Survival after lung transplantation is limited in large part due to the high incidence of chronic rejection, known as chronic lung allograft dysfunction (CLAD). Pulmonary infections are a frequent complication in lung transplant recipients, due both to immunosuppressive medications and constant exposure of the lung allograft to the external environment via the airways. Infection is a recognized risk factor for the development of CLAD, and both acute infection and chronic lung allograft colonization with microorganisms increase the risk for CLAD. Acute infection by community acquired respiratory viruses, and the bacteria Pseudomonas aeruginosa and Staphylococcus aureus are increasingly recognized as important risk factors for CLAD. Colonization by the fungus Aspergillus may also augment the risk of CLAD. Fostering this transition from healthy lung to CLAD in each of these infectious episodes is the persistence of an inflammatory lung allograft environment.

摘要

肺移植后的生存率在很大程度上受到限制,这主要是由于慢性排斥反应的高发生率,即所谓的慢性肺移植功能障碍(CLAD)。肺部感染是肺移植受者常见的并发症,这既归因于免疫抑制药物,也归因于肺移植通过气道持续暴露于外部环境。感染是公认的CLAD发生的危险因素,急性感染和肺部移植器官被微生物慢性定植都会增加CLAD的风险。社区获得性呼吸道病毒以及铜绿假单胞菌和金黄色葡萄球菌引起的急性感染越来越被认为是CLAD的重要危险因素。曲霉菌的定植也可能增加CLAD的风险。在每一次这些感染发作中,促使从健康肺向CLAD转变的是炎症性肺移植环境的持续存在。

相似文献

1
Infectious Triggers of Chronic Lung Allograft Dysfunction.
Curr Infect Dis Rep. 2016 Jul;18(7):21. doi: 10.1007/s11908-016-0529-6.
2
Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction.
Ann Am Thorac Soc. 2017 Sep;14(Supplement_3):S242-S246. doi: 10.1513/AnnalsATS.201606-464MG.
3
Fungal infection and colonization in lung transplant recipients with chronic lung allograft dysfunction.
Transpl Infect Dis. 2022 Dec;24(6):e13986. doi: 10.1111/tid.13986. Epub 2022 Nov 15.
4
Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction.
Clin Infect Dis. 2019 Sep 13;69(7):1192-1197. doi: 10.1093/cid/ciy1047.
6
Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
Scand Cardiovasc J. 2020 Jun;54(3):192-199. doi: 10.1080/14017431.2020.1726444. Epub 2020 Mar 9.
7
The Impact of Allograft CXCL9 during Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction.
OBM Transplant. 2018;2(4). doi: 10.21926/obm.transplant.1804029. Epub 2018 Nov 30.
8
Long-term outcomes and management of lung transplant recipients.
Best Pract Res Clin Anaesthesiol. 2017 Jun;31(2):285-297. doi: 10.1016/j.bpa.2017.05.006. Epub 2017 May 30.
9
Chronic lung allograft dysfunction: evolving practice.
Curr Opin Organ Transplant. 2015 Oct;20(5):483-91. doi: 10.1097/MOT.0000000000000236.

引用本文的文献

1
Towards airway microbiome engineering for improving respiratory health.
Adv Drug Deliv Rev. 2025 Aug 6;225:115662. doi: 10.1016/j.addr.2025.115662.
2
Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study.
JHLT Open. 2025 Jan 17;7:100210. doi: 10.1016/j.jhlto.2025.100210. eCollection 2025 Feb.
4
Immunopathology of lung transplantation: from infection to rejection and vice versa.
Front Immunol. 2024 Sep 2;15:1433469. doi: 10.3389/fimmu.2024.1433469. eCollection 2024.
6
Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms.
Transplantation. 2025 Mar 1;109(3):454-466. doi: 10.1097/TP.0000000000005162. Epub 2024 Aug 6.
8
Unique Changes in the Lung Microbiome following the Development of Chronic Lung Allograft Dysfunction.
Microorganisms. 2024 Jan 29;12(2):287. doi: 10.3390/microorganisms12020287.
10
Restrictive Allograft Syndrome After COVID-19 Pneumonia: A Case Report.
Cureus. 2024 Feb 20;16(2):e54583. doi: 10.7759/cureus.54583. eCollection 2024 Feb.

本文引用的文献

1
Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.
Clin Infect Dis. 2016 Feb 1;62(3):313-319. doi: 10.1093/cid/civ871. Epub 2015 Nov 12.
4
Altered Exosomal RNA Profiles in Bronchoalveolar Lavage from Lung Transplants with Acute Rejection.
Am J Respir Crit Care Med. 2015 Dec 15;192(12):1490-503. doi: 10.1164/rccm.201503-0558OC.
5
Acute Lung Injury Results from Innate Sensing of Viruses by an ER Stress Pathway.
Cell Rep. 2015 Jun 16;11(10):1591-603. doi: 10.1016/j.celrep.2015.05.012. Epub 2015 Jun 4.
7
Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis.
Mucosal Immunol. 2016 Jan;9(1):38-55. doi: 10.1038/mi.2015.34. Epub 2015 Apr 29.
8
Staphylococcus via an interaction with the ELR+ CXC chemokine ENA-78 is associated with BOS.
Am J Transplant. 2015 Mar;15(3):792-9. doi: 10.1111/ajt.13029. Epub 2015 Feb 12.
9
Viral metagenomics reveal blooms of anelloviruses in the respiratory tract of lung transplant recipients.
Am J Transplant. 2015 Jan;15(1):200-9. doi: 10.1111/ajt.13031. Epub 2014 Nov 17.
10
Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.
BMC Immunol. 2014 Oct 3;15:41. doi: 10.1186/s12865-014-0041-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验